Basma Adeem Medical company (TADAWUL:9626)

TADAWUL:9626 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Revenue	26.52	21.92
Revenue Growth (YoY)	20.99%	-
Cost of Revenue	18.2	15.02
Gross Profit	8.33	6.9
Selling, General & Admin	3.08	2.69
Operating Expenses	3.08	2.69
Operating Income	5.25	4.21
Interest Expense	-0.36	-0.29
Other Non Operating Income (Expenses)	0.17	-
Pretax Income	5.06	3.92
Income Tax Expense	0.19	0.14
Net Income	4.87	3.78
Net Income to Common	4.87	3.78
Net Income Growth	28.71%	-
Free Cash Flow	4.07	5.24
Gross Margin	31.39%	31.46%
Operating Margin	19.78%	19.20%
Profit Margin	18.36%	17.26%
Free Cash Flow Margin	15.34%	23.90%
EBITDA	5.85	4.54
EBITDA Margin	22.07%	20.71%
D&A For EBITDA	0.61	0.33
EBIT	5.25	4.21
EBIT Margin	19.78%	19.20%
Effective Tax Rate	3.69%	3.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.